Travis A. Morgan - Sep 14, 2021 Form 4 Insider Report for Future Health ESG Corp. (FHLT)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Travis A. Morgan
Stock symbol
FHLT
Transactions as of
Sep 14, 2021
Transactions value $
$267,358
Form type
4
Date filed
9/16/2021, 05:15 PM
Previous filing
Sep 9, 2021
Next filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHLT Common stock, par value $0.0001 per share Sale -$6.15K -615K -85.55% $0.01* 104K Sep 14, 2021 See Footnote F1, F2, F3
holding FHLT Common stock, par value $0.0001 per share 563K Sep 14, 2021 See Footnote F4, F5
holding FHLT Common stock, par value $0.0001 per share 2.59K Sep 14, 2021 See Footnote F6, F7
holding FHLT Common stock, par value $0.0001 per share 130K Sep 14, 2021 See Footnote F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHLT Warrant Purchase $274K +274K $1.00* 274K Sep 14, 2021 See Footnote See Footnote F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares transferred by MB Equity, LLC to anchor investors in connection with the Issuer's initial public offering at the same price per share as MB Equity, LLC initially paid for such shares.
F2 Includes up to 13,546 shares subject to forfeiture by MB Equity, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
F3 The shares are held directly by MB Equity, LLC. The Reporting Person disclaims beneficial ownership of the securities held by MB Equity, LLC other than the reported securities except to the extent of his pecuniary interest therein.
F4 Includes up to 73,406 shares subject to forfeiture by m2 Enterprises Holdings, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
F5 The shares are held directly by m2 Enterprises Holdings, LLC, of which the Reporting Person is the sole manager.
F6 Includes up to 337 shares subject to forfeiture by hc1.com, Inc. if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
F7 The shares are held directly by hc1.com, Inc. The Reporting Person disclaims beneficial ownership of the securities held by hc1.com, Inc. other than the reported securities except to the extent of his pecuniary interest therein.
F8 Includes up to 16,893 shares subject to forfeiture by Future Health ESG Associates 1, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
F9 The securities are held directly by Future Health ESG Associates 1, LLC, of which the Reporting Person is a manager, and indirectly by m2 Enterprises Holdings, LLC, an individual retirement account (IRA) in the name of the Reporting Person, and an IRA in the name of the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by Future Health ESG Associates 1, LLC other than the reported securities except to the extent of his pecuniary interest therein.
F10 Each warrant will become exercisable 30 days after the completion of the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment in the event of certain capital-raising or reorganization transactions.